Acetylcysteine
NDC 25021-812, acetylcysteine, injection, solution, from Sagent Pharmaceuticals.
- Product NDC
- 25021-812
- Status
- Listed
- Labeler
- Sagent Pharmaceuticals
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA091684
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/25021-812 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ACETYLCYSTEINE200 mg/mL
Pharmacologic classes
Antidote [EPC]; Antidote for Acetaminophen Overdose [EPC]; Decreased Respiratory Secretion Viscosity [PE]; Increased Glutathione Concentration [PE]; Mucolytic [EPC]; Reduction Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 25021-812-30 | 25021081230 | 4 VIAL in 1 CARTON (25021-812-30) / 30 mL in 1 VIAL |
| 25021-812-66 | 25021081266 | 4 VIAL in 1 CARTON (25021-812-66) / 30 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels?ndc=25021-812Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=25021-812
Use it
Look up 25021-812 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/25021-812 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 25021-812. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.